Livers after NASH remission exhibited lower FASN expression; increased AMPK phosphorylation; decreased mTOR, S6, 4E-BP1, and AKT phosphorylation. The gene discussed is EIF4EBP1; the disease is metabolic dysfunction-associated steatohepatitis.